Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
Public ClinicalTrials.gov record NCT01397968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multicenter, Double-blind, Randomized, Adjunctive, Placebo-controlled Trial With an Open-label Extension to Evaluate the Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
Study identification
- NCT ID
- NCT01397968
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- SK Life Science, Inc.
- Industry
- Enrollment
- 222 participants
Conditions and interventions
Conditions
Interventions
- YKP3089 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2011
- Primary completion
- May 31, 2013
- Completion
- Jan 27, 2021
- Last update posted
- Apr 10, 2022
2011 – 2021
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph Hospital & Medical Center/Barrow Neurology Clinic | Phoenix | Arizona | 85013 | — |
| Clinical Trials, Inc. | Little Rock | Arkansas | 72205 | — |
| Kaiser Permanente | Anaheim | California | 92806 | — |
| VA Greater Los Angeles Healthcare System | Los Angeles | California | 90073 | — |
| Bradenton Research Center, Inc. | Bradenton | Florida | 34205 | — |
| Bluegrass Epilepsy Research, LLC | Lexington | Kentucky | 40504 | — |
| John's Hopkins University School of Medicine | Baltimore | Maryland | 21287 | — |
| Mid-Atlantic Epilepsy and Sleep Center | Bethesda | Maryland | 20817 | — |
| Suite 209 South | Chesterfield | Missouri | 63017 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| The University of Toledo | Toledo | Ohio | 43614 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| University of Pennsylvania Health System | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University Comprehensive Epilepsy Center | Philadelphia | Pennsylvania | 19107 | — |
| Neurological Clinic of Texas, P.A. | Dallas | Texas | 75230 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01397968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 10, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01397968 live on ClinicalTrials.gov.